In Brief This Week: Dana-Farber Cancer Institute; Thermo Fisher; Pathogenica; Trovagene; Interleukin Genetics | GenomeWeb

NEW YORK (GenomeWeb News) – The Dana-Farber Cancer Institute is raising $50.9 million from bond sales to fund the outfitting of a new research space it has leased at Boston's Longwood Center, a new nine story building located in a major medical research hub.

The funding will be used to fit out and equip a roughly 154,000 square-foot lab spread over four floors that will include a biology lab, a chemistry lab, a lab that can serve as either a biology or chemistry lab, a dry lab, and a glass washing space, and other facilities.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: role for epigenetic in neuronal excitability, and more.

The new Office of Research Integrity director is grappling with complaints from her staff, according to ScienceInsider.

Italian researchers link SNPs in the PDSS2 gene to coffee consumption in a new paper.

A gene-editing ban has been interpreted to include mitochondrial transfer, Technology Review reports.